PB-223, A Novel Antibody Drug Conjugate Targeting Truncated Core-2 Glycans in Solid Tumors

Name: PB-223, A Novel Antibody Drug Conjugate Targeting Truncated Core-2 Glycans in Solid Tumors
Start: 2027-04-14T11:20
End: 2027-04-14
Location: Boston Convention & Exhibition Center (BCEC)

Festival of Biologics USA · 14 April 2027 · 11:20

PB-223, A Novel Antibody Drug Conjugate Targeting Truncated Core-2 Glycans in Solid Tumors was a session at Festival of Biologics USA on 14 April 2027 in Boston, with 1 speaker on record.

Speakers

Philip Arlen — Speaker President And Chief Executive Officer, Precision Biologics Inc